Tailoring modifications in labrenzin synthesis: a‐la‐carte production of pathway intermediates
Microbial Biotechnology · 2024
DOI: 10.1111/1751-7915.14355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, 2024. Verfasst von Dina Kačar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigac…. Hauptthemen laut MEDLINE: Bacteria, Polyketides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Ministerio de Economía y Competitividad.
Abstract (Originalsprache)
Pederin‐family polyketides today constitute a group of more than 30 molecules being produced as natural products by different microorganisms across multitude of ecological niches. They are mostly known for their extreme cytotoxic activity and the decades of long exploration as potential antitumor drugs. The difference in their potency and biological activity lies in the tailoring modifications of the core molecule. Despite the isolation of many pederin‐like molecules until the date, only marine bacterium Labrenzia sp. PHM005 was reported as a cultivable producer and able to be genetically modified. Here, we study the role of tailoring enzymes from the lab gene cluster responsible for methylation and hydroxylation of labrenzin core molecule. We managed to produce a spectrum of differently tailored labrenzin analogs for the development of future drugs. This work constitutes one‐step forward in understanding the biosynthesis of pederin‐family polyketides and provides the tools to modify and overproduce these anticancer drugs in a‐la‐carte manner in Labrenzia sp. PHM005, but also in other producers in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
- Research and Development Department, PharmaMar S.A., Madrid, Spain.
- UnolabManufacturing, Madrid, Spain.
ORCID-Profile: José Luis García, Beatriz Galán
Förderung
- Ministerio de Ciencia e Innovación
- Ministerio de Economía y Competitividad
Zitieren
APA
Kačar, D., Cañedo, L. M., Rodríguez, P., Schleissner, C., de la Calle, F., García, J. L., & Galán, B. (2024). Tailoring modifications in labrenzin synthesis: a‐la‐carte production of pathway intermediates. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.14355
Vancouver
Kačar D, Cañedo LM, Rodríguez P, Schleissner C, de la Calle F, García JL, et al. Tailoring modifications in labrenzin synthesis: a‐la‐carte production of pathway intermediates. Microbial Biotechnology. 2024. doi:10.1111/1751-7915.14355
BibTeX
@article{Kaar2024,
author = {Kačar, Dina and Cañedo, Librada M and Rodríguez, Pilar and Schleissner, Carmen and de la Calle, Fernando and García, José Luis and Galán, Beatriz},
title = {Tailoring modifications in labrenzin synthesis: a‐la‐carte production of pathway intermediates},
journal = {Microbial Biotechnology},
year = {2024},
doi = {10.1111/1751-7915.14355}
}
EUVIMED